Brenda M Gannon

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Molecular Docking

Randomized Controlled Trial

Bipolar Disorder

Top Venues

The Journal of pharmacology and experimental therapeutics

Pharmacological reviews

Journal of the experimental analysis of behavior

This page only lists publications with an associated author ORCID identifier.

Publications

Conor H Murray, Brenda M Gannon, Peter J Winsauer, Ziva D Cooper, Marcus S Delatte
The Development of Cannabinoids as Therapeutic Agents in the United States. Pharmacological reviews 76 (5) (2024)
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents. The Journal of pharmacology and experimental therapeutics 390 (1) (2024)
Conor H Murray, Brenda M Gannon, Peter J Winsauer, Ziva D Cooper, Marcus S Delatte
The development of cannabinoids as therapeutic agents in the United States. Pharmacological reviews (2024)
Conor H Murray, Brenda M Gannon, Peter J Winsauer, Ziva D Cooper, Marcus S Delatte
The Development of Cannabinoids as Therapeutic Agents in the United States. Pharmacological reviews 76 (5) (2024)
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents. The Journal of pharmacology and experimental therapeutics 390 (1) (2024)
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents. The Journal of pharmacology and experimental therapeutics 390 (1) (2024)
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-like abuse liability and psychosis-like neurocognitive effects of novel arylcyclohexylamine drugs of abuse in rodents . The Journal of pharmacology and experimental therapeutics (2024)
Hannah E Shaw, Dylan R Patel, Brenda M Gannon, Lauren R Fitzgerald, Theresa M Carbonaro, Chad R Johnson, William E Fantegrossi
Phencyclidine-Like Abuse Liability and Psychosis-Like Neurocognitive Effects of Novel Arylcyclohexylamine Drugs of Abuse in Rodents. The Journal of pharmacology and experimental therapeutics 390 (1) (2024)
Conor H Murray, Brenda M Gannon, Peter J Winsauer, Ziva D Cooper, Marcus S Delatte
The development of cannabinoids as therapeutic agents in the United States. Pharmacological reviews (2024)
Conor H Murray, Brenda M Gannon, Peter J Winsauer, Ziva D Cooper, Marcus S Delatte
The Development of Cannabinoids as Therapeutic Agents in the United States. Pharmacological reviews 76 (5) (2024)
William E Fantegrossi, Brenda M Gannon
A "Furious" Effort to Develop Novel 3,4-Methylenedioxymethamphetamine-Like Therapeutics. The Journal of pharmacology and experimental therapeutics 391 (1) (2024)
Michelle R Doyle, Brenda M Gannon, Melson P Mesmin, Gregory T Collins
Application of dose-addition analyses to characterize the abuse-related effects of drug mixtures. Journal of the experimental analysis of behavior 117 (3) (2022)